Bausch + Lomb Corp (BLCO) support and resistance · rev $4.79B
Bausch + Lomb Corp (BLCO) is a medical instruments & supplies company listed on NYSE.
This page maps Bausch + Lomb Corp (BLCO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BLCO revenue for 2024-12-31 was $4.79B. Net income was -$305.0M. Revenue was up 15.6% from 2023-12-31 to 2024-12-31. BLCO currently screens at market cap $5.38B.
BLCO currently screens at market cap $5.38B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BLCO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BLCO quote page for the session range and the stock page for the full model.
Not investment advice.